1. AHRO : Austin Health Research Online

Paul L R Mitchell

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Credit Name
Paul L R Mitchell
Full Name
Mitchell, Paul L R
 
Department
 
Loading... 2 0 20 0 false
Loading... 3 0 20 0 false

Publications

Refined By:
Subject:  Female
Subject:  Neoplasm Staging

Results 1-4 of 4 (Search time: 0.008 seconds).

Publication YearTitleAuthor(s)
19-Dec-2013Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.Butts, Charles; Socinski, Mark A; Mitchell, Paul L R ; Thatcher, Nick; Havel, Libor; Krzakowski, Maciej; Nawrocki, Sergiusz; Ciuleanu, Tudor-Eliade; Bosquée, Lionel; Trigo, José Manuel; Spira, Alexander; Tremblay, Lise; Nyman, Jan; Ramlau, Rodryg; Wickart-Johansson, Gun; Ellis, Peter; Gladkov, Oleg; Pereira, José Rodrigues; Eberhardt, Wilfried Ernst Erich; Helwig, Christoph; Schröder, Andreas; Shepherd, Frances A
216-Oct-2013Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer.Liew, Mun Sem; Sia, Joseph; Starmans, Maud H W; Tafreshi, Ali; Harris, Sam; Feigen, Malcolm; White, Shane C; Zimet, Allan; Lambin, Philippe; Boutros, Paul C; Mitchell, Paul L R ; John, Thomas 
317-Nov-2009High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer.Azad, Arun A; Chionh, Fiona; Scott, Andrew M ; Lee, Szeting T; Berlangieri, Salvatore U ; White, Shane C; Mitchell, Paul L R 
421-May-2007Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.Lee, S T; Berlangieri, Salvatore U ; Poon, A M T; Mitchell, Paul L R ; Pathmaraj, K ; Tabone, K; Byrne, Amanda J; O'Keefe, Graeme J; Knight, Simon R ; Clarke, C Peter; Scott, Andrew M